Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroglide Lymphatic Response Assessment
NCT05946837Phase 1Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2023
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by UTHealth Houston. Primary endpoint: Change in frequency of lymphatic pulsing. Started Aug 2023; status: completed.
Beyond the preview
Go deeper on NCT05946837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05946837.